Prostate Cancer - Results from #1820

Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta-analysis. November 24, 2023

MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression. November 24, 2023

Benefit and harm of lymphadenectomy in intermediate risk prostate cancer: comparison of five nomograms. November 24, 2023

Men's Acceptance of Screening for Prostate Cancer with Prostate-specific Antigen, Magnetic Resonance Imaging, and Prostate Biopsy. November 24, 2023

Uncovering prostate cancer aggressiveness signal in T2-weighted MRI through a three-reference tissues normalization technique. November 23, 2023

A common germline variant in CYP11B1 is associated with adverse clinical outcome of treatment with abiraterone or enzalutamide. November 23, 2023

Treatment-Related Cognitive Impairment in Patients with Prostate Cancer: Patients' Real-World Insights for Optimizing Outcomes. November 23, 2023

Multiparametric MRI-based 5-year Risk Prediction Model for Biochemical Recurrence of Prostate Cancer after Radical Prostatectomy. November 23, 2023

Organisation and delivery of supportive services for patients with prostate cancer in the National Health Service in England and Wales: a national cross-sectional hospital survey and latent class analysis. November 23, 2023

A feasibility study of adaptive radiation therapy for postprostatectomy prostate cancer. November 22, 2023

Randomized trial of concomitant hypofractionated IMRT boost versus conventional fractionated IMRT boost for localized high-risk prostate cancer (pHART2-RCT). November 22, 2023

Practical Use of Self-Adjusted Nitrous Oxide (SANO) During Transrectal Prostate Biopsy: A Double-Blind Randomized-Control Trial. November 22, 2023

Is there a role for radical prostatectomy in the management of oligometastatic prostate cancer? A systematic review. November 22, 2023

Protocol for SNOTOB study: radical prostatectomy without prostate biopsy following 18F-PSMA-1007 PET/CT based on a diagnostic model: a single-centre, single-arm, open-label study. November 22, 2023

Prostate-Specific Membrane Antigen-Ligand Therapy: What the Radiologist Needs to Know. November 21, 2023

Combination therapy with poly(adenosine diphosphate-ribose) polymerase (PARPi) and androgen receptor signaling pathway (ARPi) inhibitors for metastatic castration-resistant prostate cancer. November 21, 2023

The Molecular, Immunologic, and Clinicodemographic Landscape of MYC-Amplified Advanced Prostate Cancer. November 21, 2023

Home-based versus supervised group exercise in men with prostate cancer on androgen deprivation therapy: A randomized controlled trial and economic analysis. November 21, 2023

Diagnostic Accuracy of Liquid Biomarkers for Clinically Significant Prostate Cancer Detection: A Systematic Review and Diagnostic Meta-analysis of Multiple Thresholds. November 21, 2023

A comparison of prostate health index, total PSA, %free PSA, and proPSA in a contemporary US population-The MiCheck-01 prospective trial. November 21, 2023

Page 92 of 1439